85 related articles for article (PubMed ID: 25418013)
1. Prognostic role of EphA2 in various human carcinomas: a meta-analysis of 23 related studies.
Shen W; Xi H; Zhang K; Cui J; Li J; Wang N; Wei B; Chen L
Growth Factors; 2014 Dec; 32(6):247-53. PubMed ID: 25418013
[TBL] [Abstract][Full Text] [Related]
2. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
Kinch MS; Moore MB; Harpole DH
Clin Cancer Res; 2003 Feb; 9(2):613-8. PubMed ID: 12576426
[TBL] [Abstract][Full Text] [Related]
4. Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
Holm R; Knopp S; Suo Z; Tropè C; Nesland JM
J Clin Pathol; 2007 Oct; 60(10):1086-91. PubMed ID: 17158642
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
6. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
7. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome.
Shao Z; Zhang WF; Chen XM; Shang ZJ
Oral Oncol; 2008 Dec; 44(12):1110-7. PubMed ID: 18485799
[TBL] [Abstract][Full Text] [Related]
8. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
10. HE4 expression in lung cancer, a meta-analysis.
Zhong H; Qian Y; Fang S; Yang L; Li L; Gu W
Clin Chim Acta; 2017 Jul; 470():109-114. PubMed ID: 28499820
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of long non-coding RNA MALAT-1 in various human carcinomas: a meta-analysis.
Wang J; Xu AM; Zhang JY; He XM; Pan YS; Cheng G; Qin C; Hua LX; Wang ZJ
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909935
[TBL] [Abstract][Full Text] [Related]
13. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.
Huang X; Shen W; Xi H; Zhang K; Cui J; Wei B; Chen L
Oncotarget; 2016 Dec; 7(49):81003-81011. PubMed ID: 27768590
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.
Zhu X; Zhang F; Zhang W; He J; Zhao Y; Chen X
J Surg Oncol; 2013 Nov; 108(6):387-97. PubMed ID: 24038070
[TBL] [Abstract][Full Text] [Related]
16. [Overexpression of the receptor tyrosine kinase EphA2 in choroidal melanoma: correlation with vesculogenic mimicry and prognosis].
Chen LX; Sun BC; Li XR; He YJ; Song GX
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):985-90. PubMed ID: 23302271
[TBL] [Abstract][Full Text] [Related]
17. [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas].
Han LP; Liu JF; Liu XR; Dong ZM; Suo ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):179-84. PubMed ID: 21500549
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis.
Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z
J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340
[No Abstract] [Full Text] [Related]
19. The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis.
Xing X; Cai W; Shi H; Wang Y; Li M; Jiao J; Chen M
Br J Cancer; 2013 Jun; 108(12):2542-8. PubMed ID: 23703248
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]